Virginia Cannabis Software

Virginia Cannabis License Types

Virginia's cannabis regulatory landscape is at a pivotal transition point. The state has operated an active medical cannabis program since 2020, administered by the Virginia Cannabis Control Authority (CCA) under Title 4.1 of the Code of Virginia. On a parallel track, the Virginia General Assembly passed House Bill 642 on March 14, 2026 comprehensive adult-use retail legislation that was sent to Governor Abigail Spanberger's desk pending signature. If signed as widely expected, HB 642 would establish a statewide adult-use licensing framework with retail sales authorized beginning January 1, 2027.

Operators and prospective licensees should be aware that the adult-use license types described in this page are drawn from HB 642 as passed by the General Assembly. Final regulations are required to be promulgated by the CCA no later than September 1, 2026. Fee schedules, specific application requirements, and operational details for adult-use license types will be established through that rulemaking process. The medical cannabis program's Pharmaceutical Processor permit and Cannabis Dispensing Facility permit are active, fully operational, and governed by current CCA regulations effective January 1, 2024.

Pharmaceutical Processor Permit (Medical Cannabis)

Virginia's medical cannabis program is built around a single, vertically integrated license type: the Pharmaceutical Processor permit. A pharmaceutical processor is authorized to cultivate cannabis plants, produce cannabis products, and dispense those products directly to qualified patients all under one permit. Virginia does not issue separate cultivation-only, manufacturing-only, or dispensing-only licenses for the medical market. All cannabis products dispensed to medical patients in Virginia must be cultivated and produced by a pharmaceutical processor holding a valid CCA permit; no third-party sourcing between processors is permitted.

Under CCA regulations, a maximum of five pharmaceutical processor permits may be issued statewide one per each of the five health service areas established by the Virginia Department of Health. This geographic structure ensures that at least one licensed medical operator serves each region of the Commonwealth. Applications for pharmaceutical processor permits are accepted exclusively during open Notice of Open Application (NOA) periods, which are announced on the CCA website. Applications submitted outside an active NOA period are not accepted.

The application process occurs in four stages: initial application submission, application review and scoring by the CCA, conditional approval, and final permit issuance. Applicants who receive conditional approval have one year to fulfill all remaining requirements and receive their permit. The non-refundable application fee is $18,000. The initial permit fee upon issuance is $165,000, and the annual renewal fee is $132,000.

Pharmaceutical processor cultivation is restricted to indoor operations only. Under the framework being transitioned by HB 642, existing processors are subject to a maximum combined canopy of 70,000 square feet across all of their facilities. All cannabis produced must remain within Virginia's supply chain interstate transportation of cannabis products is a federal crime and is not authorized under state law.

Adult-Use Transition for Existing Processors: Under HB 642, existing pharmaceutical processor permit holders may convert to dual-use operations serving both medical patients and adult-use consumers by submitting an application to the CCA and paying a $10 million conversion fee, which may be paid in installments over a three-year period. Existing permits that have not received dual-use verification from the CCA become invalid as of December 1, 2026. This creates an urgent decision point for current medical operators: processors must either secure dual-use status before December 1, 2026 or risk operating under an invalid permit. The conversion fee and transition timeline reflect the legislature's decision to treat existing operators' transition to the adult-use market as a separate, compensated event rather than a free conversion of existing licenses.

Cannabis Dispensing Facility Permit (Medical Cannabis)

A cannabis dispensing facility permit authorizes a retail dispensing location to sell medical cannabis products to qualified patients and their registered agents. Dispensing facilities are the patient-facing component of a pharmaceutical processor's operations. Under CCA regulations, up to five cannabis dispensing facility permits may be issued within each health service area, and each dispensing facility must be owned at least in part by the pharmaceutical processor permitted in that same area. A pharmaceutical processor cannot open a dispensing facility that is not affiliated with its own permit, and no independent dispensing facility may exist apart from a pharmaceutical processor.

Like pharmaceutical processor permits, cannabis dispensing facility applications are accepted only during open NOA periods. The non-refundable application fee is $5,000. The initial permit fee upon issuance is $80,000, and the annual renewal fee is $64,000.

All medical cannabis products dispensed at a Virginia dispensing facility must have been cultivated and produced by the affiliated pharmaceutical processor. Dispensaries may not source products from other processors or from out-of-state suppliers. Patients must present a valid written certification from a CCA-registered practitioner to receive cannabis products. As of December 1, 2025, all medical cannabis certifications in Virginia are issued exclusively through the CCA Portal in electronic format, replacing the prior paper certification system.

Adult-Use License Types Under HB 642

The following license types are established by HB 642 as passed by the Virginia General Assembly on March 14, 2026. The CCA is required to open applications no later than July 1, 2026, promulgate final regulations by September 1, 2026, and permit no retail sales before January 1, 2027. Specific fee schedules and detailed application requirements will be published by the CCA through its rulemaking process prior to the application window opening.

Marijuana Cultivation Facility License

A marijuana cultivation facility license authorizes an establishment to cultivate cannabis plants for sale into the adult-use supply chain. Cultivation is restricted to indoor operations only under HB 642. Licenses are issued in tiers based on canopy size, with Tier V representing the largest allowable footprint at up to 35,000 square feet of plant canopy. HB 642 caps the total number of cultivation facility licenses at 450 statewide through January 1, 2028. The number of Tier V licenses is further capped at 5 before January 1, 2028, ensuring that large-scale cultivation operations do not dominate the initial market before smaller operators can establish themselves. Cultivation licenses are expected to be subject to a lottery if the number of qualified applicants exceeds available licenses for a given tier.

Marijuana Manufacturing Facility License

A marijuana manufacturing facility license authorizes an establishment to process cannabis into finished products including concentrates, edibles, tinctures, topicals, and vape products for distribution to wholesalers and retail stores. Manufacturing facilities may not sell directly to the general public. HB 642 caps the total number of manufacturing facility licenses at 60 statewide. As with cultivation, a lottery system will apply if qualified applications exceed available licenses. CCA regulations promulgated by September 1, 2026 will establish specific extraction method authorizations, packaging and labeling requirements, and product standards governing manufacturing operations.

Retail Marijuana Store License

A retail marijuana store license authorizes an establishment to sell adult-use cannabis and cannabis products directly to consumers aged 21 and older. In a single transaction, a customer may purchase up to 2.5 ounces of cannabis flower or an equivalent amount in cannabis products. Edible products are capped at 10 milligrams of THC per serving and 100 milligrams per package. HB 642 caps retail marijuana store licenses at 350 statewide through January 1, 2028.

At least 50% of retail licenses issued in the first licensing round must be awarded to Impact License applicants a social equity designation for operators who meet at least four of seven race-neutral criteria tied to prior cannabis criminalization, agricultural distress, or geographic disadvantage. This reservation is designed to ensure meaningful market participation by communities disproportionately affected by prior cannabis enforcement.

HB 642 does not permit localities to opt out of retail cannabis sales. Unlike some prior legislative proposals that included local referendum mechanisms, the final bill establishes a statewide retail program that applies uniformly across all jurisdictions. Localities may, however, elect whether to impose the additional local option cannabis tax of 1% to 3.5%. No cannabis retail establishment may be located within a facility where alcohol, tobacco, or tobacco products are manufactured, sold, or used.

Marijuana Wholesaler License

A marijuana wholesaler license authorizes an establishment to purchase cannabis and cannabis products from licensed cultivators and manufacturers and distribute them to licensed retail stores. Wholesalers may not sell to the general public. HB 642 caps wholesaler licenses at 25 statewide. The wholesale tier provides a critical logistics and distribution function in Virginia's supply chain, particularly as the market scales beyond the initial cohort of cultivators and manufacturers.

Marijuana Testing Facility License

A marijuana testing facility license authorizes an independent laboratory to test cannabis and cannabis products for potency, contaminants, and regulatory compliance before products enter the retail supply chain. All cannabis and cannabis products sold in Virginia's adult-use market must be tested by a licensed testing facility prior to distribution. Testing facility licensees are firewalled from ownership interests in other cannabis license types under HB 642, preserving the independence of compliance testing from the commercial interests of cultivators, manufacturers, and retailers. Testing and labeling requirements will be established in detail through CCA rulemaking by September 1, 2026.

Microbusiness (Impact) License

HB 642 creates a microbusiness license also referred to as an Impact License designed for small operators and social equity applicants to enter the market prior to the full retail launch. The CCA is required to issue up to 100 microbusiness licenses by December 1, 2026. Eligible applicants include qualifying hemp growers, industrial hemp processors, and individuals meeting the Impact License criteria. A microbusiness license authorizes limited cultivation, processing, and direct-to-consumer sales including delivery, allowing these operators to begin building customer relationships and supply chain operations before the broader retail market opens on January 1, 2027. Additionally, by December 1, 2026, up to 10 marijuana cultivation facility licenses and 10 marijuana manufacturing facility licenses may be issued specifically to industrial hemp growers or processors upon payment of a $500,000 conversion fee.

Application Process and Key Timelines

The CCA is required to develop application materials and open the adult-use license application window no later than July 1, 2026. Final regulations governing all adult-use license types must be promulgated by September 1, 2026. Where the number of qualified applicants for a given license type exceeds the number of available licenses, HB 642 directs the CCA to award licenses through a qualified lottery.

All adult-use cannabis licensees are required to enter into a labor peace agreement with a bona fide labor organization as a condition of licensure. This requirement applies across all license types and is intended to ensure that Virginia's cannabis workforce has access to organized labor protections from the outset of the legal market.

Seed-to-sale tracking is required to begin September 1, 2026, ahead of retail sales. The CCA will establish the specific tracking system and reporting requirements through regulation. Virginia's Alcoholic Beverage Control Authority (ABC) will take the lead on enforcement of illegal cannabis activity, while the CCA will handle licensing and regulation of the legal marketplace. By 2028, the CCA is slated to merge into ABC to form the Virginia Alcoholic Beverage Cannabis Control Authority, creating a combined regulatory body.

Taxation

Adult-use cannabis sales in Virginia will be subject to a 6% state cannabis excise tax in addition to the standard state sales and use tax. Localities may adopt an additional local option tax of 1% to 3.5%, resulting in a combined effective tax burden that will typically range from approximately 12% to 16% depending on the jurisdiction. Medical cannabis sold through pharmaceutical processors and dispensing facilities under the current medical program is not subject to the adult-use excise tax structure, though the transition framework under HB 642 will govern how existing medical operations are taxed once dual-use operations commence.